Kepos Capital LP
Position in DMII — Drugs Made In America Acquisition II Corp.
CIK 1512020
NEW YORK, NY
Position in DMII
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,112,600
+$4,200 QoQ
Shares Held
398,400
+89.7% QoQ
Ownership
0.625%
of shares outstanding
% of Portfolio
3.20%
of 13F equity value
Holder Rank
#45
of 71 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DMII Over Time
Shares Held
Position Value (USD)
Position in Shell Companies
Financial Services · as of Jun 30, 2026Kepos Capital LP holds $58,666,345 across 103 Shell Companies names. DMII ranks #4 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGCFU |
Cartesian Growth Corp IV
|
225,000 | $2,250,000 | |
| 2 | FTHA |
Forefront Tech Holdings Acquisition Corp
|
337,500 | $2,227,500 | |
| 3 | PTOR |
Praetorian Acquisition Corp.
|
286,932 | $2,211,401 | |
| 4 | DMII |
Drugs Made In America Acquisition II Corp.
This page
|
398,400 | $2,112,600 | |
| 5 | CTAA |
Clearthink 1 Acquisition Corp.
|
392,000 | $1,982,000 | |
| 6 | XSLL |
Xsolla SPAC 1
|
274,150 | $1,831,500 | |
| 7 | OHAC |
Oceanhawk Acquisition Corp.
|
180,500 | $1,786,950 | |
| 8 | AACI |
Armada Acquisition Corp. III
|
210,000 | $1,498,500 |
All Filings in DMII
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 DMIIR | — | 188,400 | Shares | Sole | 2026-08-13 | |
| 2026-06-30 | $2,112,600 | 210,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 DMIIU | $2,108,400 | 210,000 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||